Aarkstore.com announces, The Latest market research report is available inits vast collection:B-Cell Non-Hodgkin Lymphoma ...
companies and universities/research institutes based on information derived fromcompany and industry-specific sources.- Co...
Companies Involved in B-Cell Non-Hodgkin Lymphoma Therapeutics Development28Bristol-Myers Squibb Company 28Johnson & Johns...
Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) ...
Upcoming SlideShare
Loading in …5
×

B cell non-hodgkin lymphoma – pipeline

245 views

Published on

Aarkstore Enterprise-B cell non-hodgkin lymphoma – pipeline

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
245
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
5
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

B cell non-hodgkin lymphoma – pipeline

  1. 1. Aarkstore.com announces, The Latest market research report is available inits vast collection:B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, B-Cell Non-Hodgkin Lymphoma - Pipeline Review, GlobalMarkets Direct’s, B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2012,provides an overview of the indication’s therapeutic pipeline. This report providesinformation on the therapeutic development for B-Cell Non-Hodgkin Lymphoma,complete with latest updates, and special features on late-stage and discontinuedprojects. It also reviews key players involved in the therapeutic development for B-Cell Non-Hodgkin Lymphoma. B-Cell Non-Hodgkin Lymphoma - Pipeline Review,Half Year is built using data and information sourced from Global Markets Direct’sproprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for B-Cell Non-Hodgkin Lymphoma.- A review of the B-Cell Non-Hodgkin Lymphoma products under development by
  2. 2. companies and universities/research institutes based on information derived fromcompany and industry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.Reasons to buy- Identify and understand important and diverse types of therapeutics underdevelopment for B-Cell Non-Hodgkin Lymphoma.- Identify emerging players with potentially strong product portfolio and designeffective counter-strategies to gain competitive advantage.Table of contents:List of Tables 6List of Figures 7Introduction 8Global Markets Direct Report Coverage 8B-Cell Non-Hodgkin Lymphoma Overview 9Therapeutics Development 10An Overview of Pipeline Products for B-Cell Non-Hodgkin Lymphoma 10B-Cell Non-Hodgkin Lymphoma Therapeutics under Development by Companies 12B-Cell Non-Hodgkin Lymphoma Therapeutics under Investigation byUniversities/Institutes 15Late Stage Products 18Comparative Analysis 18Mid Clinical Stage Products 19Comparative Analysis 19Early Clinical Stage Products 20Comparative Analysis 20Discovery and Pre-Clinical Stage Products 21Comparative Analysis 21B-Cell Non-Hodgkin Lymphoma Therapeutics – Products under Development byCompanies 22B-Cell Non-Hodgkin Lymphoma Therapeutics – Products under Investigation byUniversities/Institutes 24
  3. 3. Companies Involved in B-Cell Non-Hodgkin Lymphoma Therapeutics Development28Bristol-Myers Squibb Company 28Johnson & Johnson 29Kyowa Hakko Kirin Co., Ltd. 30Sanofi-Aventis 31Genentech, Inc. 32MedImmune LLC 33Gilead Sciences, Inc. 34List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H22012&PubId=&pagenum=1 Liver Cancer – Pipeline Review, H2 2012 Non-Small Cell Lung Cancer – Pipeline Review, H2 2012 Asthma – Pipeline Review, H2 2012 Multiple Sclerosis – Pipeline Review, H2 2012 Gastrointestinal Tract Cancer – Pipeline Review, H2 2012 Diabetes – Pipeline Review, H2 2012
  4. 4. Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,H2 2012 Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012 Malaria – Pipeline Review, H2 2012 Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,H2 2012 Dermatitis – Pipeline Review, H2 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com

×